Abstract
Aims
The background was to analyse the influence of hospital- and surgeon volume and of
the extent of resective procedures on the quality of early and late treatment results
in gastric cancer.
Methods
The literature was reviewed by searching the databases of Medline, Cancerlit, Pubmed
and the Cochran register.
Results
The levels of evidence showed wide variations. The influence of hospital volume was
more important for the outcome than the case load of the individual surgeon. The extent
of surgical resection should be adapted to histology—or stage. The value of systematic
lymph node dissection is still under discussion.
Conclusions
We have found that the best treatment results were seen in high volume hospitals with
experienced surgeons, even taking into account extended surgical procedures. Further
studies are needed to define the optimal number of operations necessary to be carried
out each year.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Surgical OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Surgery for gastric cancer: 10-year experience worldwide.Gastric Cancer. 2001; 4: 166-174
- Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients.World J Surg. 1993; 17: 410-414
- Total gastrectomy is not necessary for proximal gastric cancer.Surgery. 1998; 123: 127-130
- Lymph node dissection for gastric cancer.Semin Surg Oncol. 1999; 17: 117-124
- Prognostic factors in gastric carcinoma.Cancer. 1993; 72: 2089-2097
- Potential and futility of sentinel node detection for gastric cancer.Recent Results Cancer Res. 2000; 157: 259-269
- The importance of quality assurance in surgical oncology.Eur J Surg Oncol. 2002; 28: 571-602
- Influence of surgery on outcomes in gastric cancer.Surg Oncol Clin N Am. 2000; 9: 97-117
- The surgeon as a prognostic factor.Ann Surg. 2000; 6: 729-732
- The volume-outcome relationship in cancer surgery.Ann Surg. 2003; 6: 777-781
- Differenziertes chirurgisches Vorgehen bei der kurativen Therapie des Magencarcinoms.Leber Magen Darm. 1996; 26: 64-72
- Perspectives of surgery and multimodality treatment in gastric carcinoma.J Cancer Res Clin Oncol. 1993; 119: 384-394
- Should operations be regionalized? The empirical relation between surgical volume and mortality.N Engl J Med. 1979; 301: 1364-1369
- Risiko der chirurgischen Therapie des Magencarcinoms in Deutschland.Chirurg. 1994; 65: 298-306
- Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers.Br J Surg. 2002; 89: 914-922
- Hospital volume and surgical mortality in the United States.N Engl J Med. 2002; 15: 1128-1137
- The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients cancer.Surgery. 2002; 131: 6-15
- Surgical workload and outcome after resection for carcinoma of the oesophagus and cardia.Br J Surg. 2002; 89: 344-348
- Influence of surgical subspeciality training on in-hospital mortality for gastrectomy and colectomy patients.Ann Surg. 2003; 4: 629-636
- Influence of surgeon's volume on early outcome after total gastrectomy.Eur J Surg. 2002; 168: 535-538
- A population-based study of tumor-node relationship, resection margins, and surgeon volume on gastric cancer survival.Am J Surg. 2003; 186: 23-27
- Hospital volume and post-operative mortality after resection for gastric cancer.Eur J Surg Oncol. 2002; 28: 401-405
- Hospital volume, length of stay, and readmission rates in high-risk surgery.Ann Surg. 2003; 2: 161-167
- Relevant prognostic factors in gastric cancer—ten-year results of the German Gastric Cancer Study.Ann Surg. 1998; 228: 449-461
Degiuli M, Sasako M, Garino M, Rebecchi F, Mineccia M, Scaglione D. In: Santoro E, Garofalo A, editors. Gastric cancer in the world 2003. Roma Edizion Scientifiche; Rome, 2003. p. 127–36.
- Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers.Gastric Cancer. 2000; 3: 219-225
- Gastric cancer treatment guidelines in Japan.Gastric Cancer. 2002; 5: 1-5
- Subtotal versus total gastrectomy for gastric cancer.Ann Surg. 1999; 230: 170-178
- Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A french prospective controlled study.Ann Surg. 1989; 209: 162
- 1114 total gastrectomies in the surgical treatment of primary gastric adenocarcinoma—a 30-year single institution experience.Hepato-Gastroenterol. 2001; 48: 1222-1226
- Kardiakarzinom: Versuch einer therapeutisch relevanten Klassifikation.Chirurg. 1987; 58: 25-34
- Adenocarcinoma of the esophagogastric junction: a summary of responses to a questionnaire on adenocarcinoma of the esophagus and the esophagogastric junction in Japan.Dis Esophagus. 2002; 15: 219-225
- Efficacy of extended lymphadenectomy in the noncurative gastrectomy for advanced gastric cancer.Hepato-Gastroenterol. 1999; 46: 2677-2682
- Can sentinel node biopsy indicate rational extent of lymphadenectomy in gastric cancer surgery?.Langenbeck's Arch Surg. 1999; 384: 149-157
- Rationale for extensive lymphadenectomy in early gastric carcinoma.Br J Cancer. 1995; 72: 1518-1523
- Japanese classification of gastric carcinoma—2nd English edition.Gastric Cancer. 1998; 1: 10-24
- Impact of D2 lymphadenectomy on morbidity and long-term survival in patients with gastric cancer.Onkologie. 1997; 20: 145-150
- Lymphadenectomy in gastric carcinoma—a prospective and prognostic study.Arch Surg. 1992; 127: 290-294
- Biological behaviour and clinical implications of micrometastases.Br J Surg. 2000; 87: 1629-1639
- Paraaortic lymph node micrometastasis and tumor cell microinvolvement in advanced gastric carcinoma.Gastric Cancer. 1999; 2: 179-185
- What is reasonable treatment for gastric adenocarcinoma?.J Gastroenterol. 2000; 35: 116-120
- Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases.Br J Surg. 1996; 83: 1144-1147
- Application of sentinel node biopsy to gastric cancer surgery.Surgery. 2001; 129: 335-340
- Radio-guided sentinel node detection for gastric cancer.Br J Surg. 2002; 89: 604-608
- Total gastrectomy with dissection of lymph nodes along the splenic artery: a pancreas-preserving method.Ann Surg. 2000; 7: 669-673
- Rationale and technique of systematic lymph node dissection in gastric carcinoma.Dig Surg. 1994; 11: 72-77
- Randomized comparison of R1- and R2-gastrectomy for gastric carcinoma.Br J Surg. 1988; 75: 110-112
- A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer.Ann Surg. 1994; 220: 176-182
- Extended lymph-node dissection for gastric cancer.N Engl J Med. 1999; 340: 908-914
- Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC-randomized surgical trial.Br J Cancer. 1999; 79: 1522-1530
- Is there any need for D2-lymphadenectomy? Results of European studies on D2-lymphadenectomy in gastric cancer.Tumori. 2002; 2: 47-49
- Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus.J Surg Oncol. 2001; 76: 89-92
- Risk factors for surgical treatment in the Dutch gastric cancer trial.Br J Surg. 1997; 84: 1567-1571
- Institutional differences in postoperative death rates.JAMA. 1968; 203: 492-498
- Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.Cochrane Database Syst Rev. 2003; 4: CD001964
Article info
Publication history
Accepted:
March 8,
2005
Identification
Copyright
© 2005 Elsevier Ltd. Published by Elsevier Inc. All rights reserved.
